How much did Medicenna raise?

Medicenna raised $6.72 Million in a funding round on March 30, 2020.

Who are the decision-makers at Medicenna?

Fundz holds 1 contact at Medicenna. Names and contact details are shown to Fundz members.

Medicenna Therapeutics Corp. reported raising $6.72 Million in an initial SEC Form D filing, from an offering of $6.72 Million

PUBLIC · MDNAFMar 30, 2020

Amount Raised

$6.72 Million

$6.72 Million sold, per SEC Form D (first sale Mar 30, 2020)

Round Type

Venture

TorontoBiotechnologyHealth CareTherapeutics

Quick answer

Medicenna raised $6.72 Million in a funding round, dated March 30, 2020. Medicenna is based in Toronto, Ontario, Canada.

How much did Medicenna raise?: Medicenna raised $6.72 Million in a funding round on March 30, 2020.
What does Medicenna do?: Medicenna is a clinical stage immunotherapy company focused on the development of novel, highly selective versions of IL-2, IL-4 and IL-13 Superkines and first in class Empowered Superkines.
Where is Medicenna based and how big is it?: Medicenna is based in Toronto, Ontario, Canada.
Who are the decision-makers at Medicenna?: Fundz holds 1 contact at Medicenna. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Medicenna that raised within 45 days of this round, from Fundz verified event records.

Lisata Therapeutics raised $2.4M (Seed) on May 12, 2020.
Ocugen raised $395 (Pre-Seed) on May 7, 2020.
Ocugen raised $14M on May 7, 2020.
Oragenics raised $4.6M (Seed) on May 6, 2020.
Os Therapies raised an undisclosed amount on May 1, 2020.
Alpha Cognition raised $1.9M (Seed) on May 1, 2020.

Who to call at Medicenna, and when

A new round usually means Medicenna is about to hire and buy. The teams that reach out first get the meeting.

An alert the day Medicenna raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Medicenna, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Medicenna. With Fundz connected, it knows.

Watch Fundz in

See plan options

Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Medicenna

Location

Toronto, Ontario, Canada

About

Medicenna is a clinical stage immunotherapy company focused on the development of novel, highly selective versions of IL-2, IL-4 and IL-13 Superkines and first in class Empowered Superkines. Medicenna's long-acting IL-2 Superkine, MDNA11, is a next-generation IL-2 with superior CD122 binding without CD25 affinity thereby preferentially stimulating cancer killing effector T cells and NK cells. Medicenna’s early-stage BiSKITs™ program, (Bifunctional SuperKine ImmunoTherapies) is designed to enhance the ability of Superkines to treat immunologically “cold” tumors. Medicenna's IL-4 Empowered Superkine, MDNA55, has been studied in 5 clinical trials including a Phase 2b trial for recurrent GBM, the most common and uniformly fatal form of brain cancer. MDNA55 has obtained Fast-Track and Orphan Drug status from the FDA and FDA/EMA, respectively.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Medicenna raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Book a demo Explore plans

Related People

1 contact

Verified contacts14 people are listed at Medicenna. We don't have their email yet.See plans and pricing

Predictive Intelligence

Strategic

ML-powered predictions for Medicenna's next move

See what Strategic adds

Medicenna raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

Show me how a sales rep uses this Or see plans and pricing →

5 screens from a live account. No signup.